Review of Drug Repositioning Approaches and Resources

Drug discovery is a time-consuming, high-investment, and high-risk process in traditional drug development. Drug repositioning has become a popular strategy in recent years. Different from traditional drug development strategies, the strategy is efficient, economical and riskless. There are usually three kinds of approaches: computational approaches, biological experimental approaches, and mixed approaches, all of which are widely used in drug repositioning. In this paper, we reviewed computational approaches and highlighted their characteristics to provide references for researchers to develop more powerful approaches. At the same time, the important findings obtained using these approaches are listed. Furthermore, we summarized 76 important resources about drug repositioning. Finally, challenges and opportunities in drug repositioning are discussed from multiple perspectives, including technology, commercial models, patents and investment.

[1]  Marko Bajec,et al.  Unfolding communities in large complex networks: Combining defensive and offensive label propagation for core extraction , 2011, Physical review. E, Statistical, nonlinear, and soft matter physics.

[2]  Ambuj K. Singh,et al.  RRW: repeated random walks on genome-scale protein networks for local cluster discovery , 2009, BMC Bioinformatics.

[3]  Xin Chen,et al.  DCDB: Drug combination database , 2010, Bioinform..

[4]  David Page,et al.  A Simple Text Mining Approach for Ranking Pairwise Associations in Biomedical Applications , 2017, CRI.

[5]  Dik-Lung Ma,et al.  Drug repositioning by structure-based virtual screening. , 2013, Chemical Society reviews.

[6]  Sean Ekins,et al.  The Collaborative Drug Discovery (CDD) database. , 2013, Methods in molecular biology.

[7]  R A Knight,et al.  DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information , 2014, Cell Death and Disease.

[8]  Seungmin Kang,et al.  Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures , 2016, PloS one.

[9]  Yanli Wang,et al.  PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .

[10]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[11]  Marti A. Hearst.  Untangling Text Data Mining , 1999, ACL.

[12]  Lin Gao,et al.  Detecting Overlapping Protein Complexes by Rough-Fuzzy Clustering in Protein-Protein Interaction Networks , 2014, PloS one.

[13]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[14]  Bin Chen,et al.  Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data , 2010, BMC Bioinformatics.

[15]  W. Alkema,et al.  Application of text mining in the biomedical domain. , 2015, Methods.

[16]  Luonan Chen,et al.  Network-based drug repositioning. , 2013, Molecular bioSystems.

[17]  Lei Chen,et al.  Identification of new candidate drugs for lung cancer using chemical–chemical interactions, chemical–protein interactions and a K-means clustering algorithm , 2016, Journal of biomolecular structure & dynamics.

[18]  Tudor I Oprea,et al.  Computational and Practical Aspects of Drug Repositioning. , 2015, Assay and drug development technologies.

[19]  Cheng Zhu,et al.  Drug repositioning for orphan diseases , 2011, Briefings Bioinform..

[20]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[21]  Xiang Zhang,et al.  Drug repositioning by integrating target information through a heterogeneous network model , 2014, Bioinform..

[22]  José Luís Oliveira,et al.  BeCAS: biomedical concept recognition services and visualization , 2013, Bioinform..

[23]  Zhiwei Cao,et al.  Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer , 2015, Nature Communications.

[24]  Thomas C. Rindflesch,et al.  EDGAR: extraction of drugs, genes and relations from the biomedical literature. , 1999, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[25]  Roded Sharan,et al.  Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..

[26]  W. Welsh,et al.  Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study , 2015, Pharmaceutical Research.

[27]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[28]  Dmitrij Frishman,et al.  MIPS: a database for protein sequences and complete genomes , 1998, Nucleic Acids Res..

[29]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[30]  D. Swinney,et al.  How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.

[31]  H. Hermeking,et al.  The MYC oncogene as a cancer drug target. , 2003, Current cancer drug targets.

[32]  Yi Pan,et al.  Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm , 2016, Bioinform..

[33]  Akhilesh Pandey,et al.  Human Protein Reference Database and Human Proteinpedia as Discovery Resources for Molecular Biotechnology , 2011, Molecular biotechnology.

[34]  Lars Juhl Jensen,et al.  EXTRACT 2.0: text-mining-assisted interactive annotation of biomedical named entities and ontology terms , 2017, bioRxiv.

[35]  Jun Zou,et al.  Advanced Systems Biology Methods in Drug Discovery and Translational Biomedicine , 2013, BioMed research international.

[36]  M. Schuemie,et al.  Anni 2.0: a multipurpose text-mining tool for the life sciences , 2008, Genome Biology.

[37]  D. Kuter.  New thrombopoietic growth factors. , 2007, Blood.

[38]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[39]  Nasser Ghadiri,et al.  A review of network‐based approaches to drug repositioning , 2018, Briefings Bioinform..

[40]  Sophia Ananiadou,et al.  Discovering and visualizing indirect associations between biomedical concepts , 2011, Bioinform..

[41]  Jaehoon Choi,et al.  BEST: Next-Generation Biomedical Entity Search Tool for Knowledge Discovery from Biomedical Literature , 2016, PloS one.

[42]  P. DeotarseP.,et al.  Drug Repositioning: A Review , 2015 .

[43]  David S. Wishart,et al.  Nucleic Acids Research Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs and Metabolites , 2008 .

[44]  Dimitrios Gunopulos,et al.  Automatic subspace clustering of high dimensional data for data mining applications , 1998, SIGMOD '98.

[45]  Gerold Schmitt-Ulms,et al.  Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining , 2016, PloS one.

[46]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[47]  J. Delvenne,et al.  Random walks on graphs , 2004 .

[48]  Martin Serrano,et al.  Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .

[49]  A. Persidis,et al.  Literature analysis for systematic drug repurposing: a case study from Biovista , 2011 .

[50]  Alfonso Valencia,et al.  Text-mining approaches in molecular biology and biomedicine. , 2005, Drug discovery today.

[51]  Julio Saez-Rodriguez,et al.  DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data , 2012, Bioinform..

[52]  Archana Agarwal,et al.  Zebrafish screen identifies novel compound with selective toxicity against leukemia. , 2012, Blood.

[53]  Alexander E. Ivliev,et al.  Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach , 2013, PloS one.

[54]  Esha T Shah,et al.  Repositioning “old” drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion , 2016, Clinical & Experimental Metastasis.

[55]  Adam E. Hendry,et al.  Chemical genetics and drug discovery in Xenopus. , 2012, Methods in molecular biology.

[56]  Ulf Leser,et al.  ALIBABA: PubMed as a graph , 2006, Bioinform..

[57]  Nada Lavrac,et al.  TextFlows: A visual programming platform for text mining and natural language processing , 2016, Sci. Comput. Program..

[58]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.

[59]  Georgios A. Pavlopoulos,et al.  DrugQuest - a text mining workflow for drug association discovery , 2016, BMC Bioinformatics.

[60]  J. Fields,et al.  Non-Peptide Arginine-Vasopressin Antagonists (Vaptans) for the Treatment of Hyponatremia in Neurocritical Care: A New Alternative? , 2009, Neurocritical care.

[61]  David J. Porteous,et al.  Speeding disease gene discovery by sequence based candidate prioritization , 2005, BMC Bioinformatics.

[62]  Hans-Peter Kriegel,et al.  OPTICS: ordering points to identify the clustering structure , 1999, SIGMOD '99.

[63]  R. P. van de Riet,et al.  Applications of Natural Language to Information Systems , 1996 .

[64]  Delbert Dueck,et al.  Clustering by Passing Messages Between Data Points , 2007, Science.

[65]  Jaime Prilusky,et al.  Proteopedia - a scientific 'wiki' bridging the rift between three-dimensional structure and function of biomacromolecules , 2008, Genome Biology.

[66]  Benjamin N. Roin.  Unpatentable Drugs and the Standards of Patentability , 2009 .

[67]  Guillermo Palma,et al.  Drug-Target Interaction Prediction Using Semantic Similarity and Edge Partitioning , 2014, SEMWEB.

[68]  Mehmet Gönen,et al.  Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization , 2012, Bioinform..

[69]  Hongfang Liu,et al.  A new method for prioritizing drug repositioning candidates extracted by literature-based discovery , 2015, 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[70]  Salvador Ventura,et al.  Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity , 2016, Nature Communications.

[71]  David L. Wheeler,et al.  GenBank , 2015, Nucleic Acids Res..

[72]  Pierre Baldi,et al.  ChemDB: a public database of small molecules and related chemoinformatics resources , 2005, Bioinform..

[73]  Chee Keong Kwoh,et al.  Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..

[74]  Lin Gao,et al.  Inferring drug-disease associations based on known protein complexes , 2015, BMC Medical Genomics.

[75]  P. Stouten,et al.  Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish , 2012, Oncogene.

[76]  Giup Jang,et al.  Literature-based prediction of novel drug indications considering relationships between entities. , 2017, Molecular bioSystems.

[77]  Tiziana di Matteo,et al.  Graph Theory Enables Drug Repurposing – How a Mathematical Model Can Drive the Discovery of Hidden Mechanisms of Action , 2013, PloS one.

[78]  Mingyao Liu,et al.  Zebrafish cancer and metastasis models for in vivo drug discovery. , 2013, Drug discovery today. Technologies.

[79]  Chao Wu,et al.  Computational drug repositioning through heterogeneous network clustering , 2013, BMC Systems Biology.

[80]  Yan Zhao,et al.  Drug repositioning: a machine-learning approach through data integration , 2013, Journal of Cheminformatics.

[81]  Xiaoyan Zhu,et al.  Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts , 2009, PLoS Comput. Biol..

[82]  I. Tannock,et al.  A critical appraisal of the "human tumor stem-cell assay". , 1983, The New England journal of medicine.

[83]  Tudor I. Oprea,et al.  Drug Repurposing from an Academic Perspective. , 2011, Drug discovery today. Therapeutic strategies.

[84]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[85]  M. Höglund,et al.  Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia , 2015, Blood Cancer Journal.

[86]  Isabel Moreno,et al.  MaNER: A MedicAl Named Entity Recogniser , 2015, NLDB.

[87]  Armando Blanco,et al.  DrugNet: Network-based drug-disease prioritization by integrating heterogeneous data , 2015, Artif. Intell. Medicine.

[88]  Hans-Peter Kriegel,et al.  Density-Based Clustering in Spatial Databases: The Algorithm GDBSCAN and Its Applications , 1998, Data Mining and Knowledge Discovery.

[89]  Peter Woollard,et al.  An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations , 2016, PloS one.

[90]  Stephen T. C. Wong,et al.  DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies , 2013, Bioinform..

[91]  Cui Tao,et al.  Exploring the Pharmacogenomics Knowledge Base (PharmGKB) for Repositioning Breast Cancer Drugs by Leveraging Web Ontology Language (OWL) and Cheminformatics Approaches , 2013, Pacific Symposium on Biocomputing.

[92]  Jiong Yang,et al.  STING: A Statistical Information Grid Approach to Spatial Data Mining , 1997, VLDB.

[93]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[94]  Bin Chen,et al.  Assessing Drug Target Association Using Semantic Linked Data , 2012, PLoS Comput. Biol..

[95]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[96]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[97]  Seong-Hoon Park,et al.  Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells. , 2011, Oncology reports.

[98]  Russ B Altman,et al.  PharmGKB: the Pharmacogenomics Knowledge Base. , 2013, Methods in molecular biology.

[99]  Marc Weeber,et al.  Using concepts in literature-based discovery: Simulating Swanson's Raynaud-fish oil and migraine-magnesium discoveries , 2001, J. Assoc. Inf. Sci. Technol..

[100]  Igor Jurisica,et al.  Protein complex prediction via cost-based clustering , 2004, Bioinform..

[101]  Sanghyun Park,et al.  Protein localization vector propagation: a method for improving the accuracy of drug repositioning. , 2015, Molecular bioSystems.